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Abstract
Background: Pulmonary tumor thrombotic microangiopathy (PTTM) has been known as a rare and serious cancer-
related pulmonary complication. However, the pathogenesis and pathophysiology of this debilitating condition still
remains obscure and no effective management was recommended. The present study aims to elucidate the
pathophysiology of PTTM.
Methods: Autopsy records were searched to extract cases of pulmonary tumor embolism induced by metastasis of
gastric carcinoma in the Toho University Omori Medical Center from 2000 to 2006. And then, tissue sections of
extracted cases were prepared for not only light microscopic observation but morphometric analysis with the use
of selected PTTM cases.
Results: Six autopsies involved PTTM and clinicopathological data of them were summarized. There was a
significant negative association between pulmonary arterial diameter and stenosis rate in four cases. Although all
cases showed an increase of stenosis rate to some degree, the degree of stenosis rate varied from case to case.
Significant differences were found for average stenosis rate between the under 100 micrometer group or the 100
to 300 micrometer group and the 300 micrometer group in four cases. However, no significant differences were
found for average stenosis rate between the under 100 micrometer group and the 100 to 300 micrometer group
in all cases. Meanwhile, all cases showed positive reactivity for tissue factor (TF), five showed positive reactivity for
vascular endothelial growth factor (VEGF), and three showed positive reactivity for osteopontin (OPN).
Conclusions: In the present study, we revealed that the degree of luminal narrowing of the pulmonary arteries
varied from case to case, and our results suggested that pulmonary hypertension in PTTM occurs in selected cases
which have a widespread pulmonary lesion with severe luminal narrowing in the smaller arteries. Furthermore, our
immunohistochemical examination indicated that gastric carcinoma indicating PTTM shows a higher TF-positive
rate than typical gastric carcinoma. However, it remains still obscuring whether gastric carcinoma indicating PTTM
shows a higher VEGF or OPN-positive rate as determined by immunohistochemistry.
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Pulmonary tumor thrombotic microangiopathy (PTTM)
is known as a rare and severe devastating cancer-related
pulmonary complication that was first reported by Von
Herbay et al. in 1990 [1]. Previous studies aimed to
determine how this unique complication developed with
metastasis of carcinoma cells. Some candidates pro-
duced by carcinoma cells were especially investigated as
ak e yf a c t o ro ft h ed i s e a s e ,s u c ha st i s s u ef a c t o r( T F )
[2-7], vascular endothelial growth factor (VEGF) [2-7],
and osteopontin (OPN) [7], and their contribution to
the development of PTTM was investigated. Clinically,
patients with PTTM often present with subacute
respiratory failure with pulmonary hypertension, right-
side heart failure, and sudden death [2-6]. PTTM is
histopathologically characterized by tumor embolism,
multiple microthrombi, and intimal myofibroblast prolif-
eration in the pulmonary arteries and arterioles [1,2].
However, the pathophysiology of this debilitating condi-
tion still remains obscure. The present study aims to
elucidate the pathophysiology of PTTM using morpho-
metric and immunohistochemical examinations of six
autopsy cases induced by metastasis of gastric
carcinoma.
Methods
Patients and clinicopathological data selection
Autopsy records were searched to extract cases of pul-
monary tumor embolism induced by metastasis of gas-
tric carcinoma in the Toho University Omori Medical
Center from 2000 to 2006. And then, paraffin-embedded
pulmonary tissue sections of these cases with pulmonary
tumor embolism induced by metastasis of gastric carci-
noma were prepared, and stained with hematoxylin and
eosin (HE) double stain and Elastica van Gieson (EVG)
stain to determine whether they satisfied the diagnostic
criteria of PTTM, histopathologically. For an accurate
histopathological diagnosis, tissues were examined by
more than three pathologists. In addition, we extracted
and sampled data from the medical records associated
with each case, such as age, sex, maximum diameter of
the tumor, macroscopic type, histopathological type,
lymph-vascular involvement, organs with metastasis, and
clinical symptoms.
Morphometric analysis of pulmonary arteries
Initially, all arterial images of pulmonary EVG-stained
sections were photographed using a digital camera. In
the present study, pulmonary arterial diameter, area
within the internal elastic lamina (IELA), and lumen
area (LA) were measured with Image J 1.36b software
(National Institutes of Health, Bethesda, MD) using
these photographed images. To evaluate the degree of
pulmonary arterial stenosis, we calculated the stenosis
rate using following formula: [1-(LA/IELA)] × 100 = ste-
nosis rate (%).
Furthermore, we focused on PTTM cases with pul-
monary hypertension. Therefore, we divided pulmonary
arteries into three groups according to the Heath and
Edwards classification [8], such as artery under 100 μm,
100 to 300 μm, or over 300 μm in diameter (designated
the ‘under 100-μm’ group, the ‘100-300-μm’ group, and
the ‘over 300-μm’ group, respectively).
To allow a more detailed discussion of PTTM, we
performed the following three investigations in each
case. First, to assess any potential relationship between
pulmonary arterial diameter and stenosis rate, we made
a scatter plot of pulmonary arterial diameter and steno-
sis rate, and Spearman’s rank correlation coefficient was
calculated. Second, to clarify the frequency of pulmon-
ary arterial lesion, the optional stenosis rate in each
arterial group was calculated. Finally, we calculated the
average stenosis rate in each arterial group and statisti-
cal significance was tested using the one-way analysis of
variance (ANOVA) and the Bonferroni post hoc test.
Differences were considered significant at P < 0.05.
Immunohistochemical examination
In the present study, the gastric and pulmonary tissue
sections in each case were used for immunohistochem-
ical examination. Polyclonal anti-VEGF-antibody
(Human vascular endothelial growth factor (polyclonal
antibody), dilution 1:50; Immuno-Biological Laboratories
Co., Gunma, Japan), monoclonal anti-TF-antibody
(Human tissue factor, 1:100; American Diagnostica Inc.,
Stamford, United States of America), and anti- OPN-
antibody (OP3N, dilution 1:100; Leica Biosystems New-
castle Ltd., Newcastle, United Kingdom) were used.
Results
Incidence of PTTM in our institute
578 autopsies were retrieved from the autopsy records
of Toho University Omori Medical Center for the per-
iod from 2000 to 2006. According to these records, it
was deemed that 37 patients died of gastric carcinoma
and a total of six cases involved pulmonary tumor
embolism induced by metastasis of gastric carcinoma.
According to the diagnostic criteria of PTTM as pro-
posed by Herbay et al. [1], we regarded these six autop-
sies as PTTM.
Summary of patient characteristics
Patient age ranged from 49 to 82 years (mean ± stan-
dard deviation (SD): 68.3 ± 11.3). The gender ratio was
4:2 (male to female). Maximum diameter of the tumor
ranged from 20 to 70 mm (mean ± SD: 45.8 ± 25.4).
Chemotherapy was given in o n ec a s e( C a s e5 ) .T r a n s -
thoracic Doppler echocardiography was used to confirm
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two cases (Case 1 and 2, respectively). As a result, case
1 and 2 involved clinically proven or denied pulmonary
hypertension, respectively. Unfortunately, no appropriate
examinations were performed in the other patients
(Case 3 to 6) and it is not known whether they suffered
from pulmonary hypertension [Table 1].
Histopathological status of surgically obtained gastric
carcinoma
In the present study, the main histology of gastric carci-
noma involved poorly differentiated adenocarcinoma
(Case 1, 2, 3, 4, and 6), while the remaining case involved
papillary adenocarcinoma (Case 5). Although all cases
more or less showed lymph-vascular involvement, lym-
phatic involvement was prominent. Furthermore, the
autopsies revealed that no patients had latent carcinomas
[Figure 1 and Table 1].
Morphometric analysis of altered pulmonary arteries
First, the scatter plot of pulmonary arterial diameter and
stenosis rate and the result of the Spearman correlation
coefficient are shown in Figure 2. According to the
Spearman correlation coefficient, there was a significant
negative association between pulmonary arterial diameter
and stenosis rate in four of the six cases (Case 1, 2, 3, and
6). In contrast, there was no significant association in the
remaining two cases (Case 4 and 5). Second, the relation-
ship between optional stenosis rate and each arterial
group is summarized in Table 2. Although all cases
showed an increase of stenosis rate to some degree, the
degree of change in stenosis rate varied from case to case
[Figure 3 and 4]. Finally, no significant differences were
found for average stenosis rate between the under 100-
μm group and the 100 to 300-μm group in all cases. On
the other hand, significant differences were found for
average stenosis rate between the under 100-μmg r o u p
or 100 to 300-μm group and the 300-μm group in four of
the six cases (Case 1, 2, 3, and 6) [Figure 5 and Table 3].
Immunohistochemical examination
No differences were found for gastric and pulmonary
tissue sections in our immunohistochemical examina-
tions. All cases showed positive reactivity for TF, five
cases showed positive reactivity for VEGF (Case 2, 3, 4,
5, and 6), and three cases showed positive reactivity for
OPN (Case 3, 5, and 6) [Figure 6 and Table 4].
Discussion
PTTM has been regarded as a rare and severe devastating
cancer-related pulmonary complication, the majority of
which is mainly induced by poorly differentiated adeno-
c a r c i n o m aa r i s i n gf r o mg a s t r i cm u c o s a[ 2 ] .A l t h o u g hi t
has been well known that the ante mortem diagnosis of
PTTM is very difficult [6], Miyano et al. reported a
PTTM case which could be determined through an ante
mortem diagnosis and the patient survived after che-
motherapy [9]. This report emphasized the necessity and
importance of intensive monitoring and prophylactic
intervention, especially in the case of advanced gastric
Table 1 Summary of patient characteristics
Case Age Sex Maximum
diameter of
tumor (mm)
Macroscopic
subtype
Histopathological
subtype
Lymph-
vascular
involvement
Metastasis Pulmonary
arterial
pressure
1 76 Male 70 Borrmann 3 por ly-3
v-2
Lung, diaphragm, pleura, peritoneum, liver,
gallbladder, pancreas, adrenal gland, lymph
nodes.
90 mmHg
2 82 Female 20 Borrmann 2 por ly-3
v-1
Lung, liver, pancreas, lymph nodes 10 mmHg
3 67 Female 30 Superficial
depressed
type
por ly-3
v-1
Lung, esophagus, thyroid, pericardium, ovary,
lymph nodes
Unknown
4 67 Female 75 Borrmann 3 por ly-3
v-1
Esophagus, duodenum, ileum, jejunum,
colon, mesenterium, liver, gallbladder,
pancreas, kidney, adrenal gland, aorta, lymph
nodes
Unknown
5 49 Female 60 Borrmann 3 pap ly-3
v-2
Esophagus, duodenum, liver, pancreas,
kidney, adrenal gland, lymph nodes
Unknown
6 72 Male 20 Borrmann 2 por ly-3
v-1
Pancreas, spleen, kidney, adrenal gland,
colon, spinal cord, lymph nodes
Unknown
por: poorly differentiated adenocarcinoma, pap: papillary adenocarcinoma, ly/v-1: minimal lympho-vascular involvement, ly/v-2: moderate lympho-vascular
involvement, ly/v-3: prominent lympho-vascular involvement.
Patient age ranged from 49 to 82 years (mean ± standard deviation: 68.3 ± 11.3). The gender ratio was 4:2 (male to female). Maximum diameter of the tumor
ranged from 20 to 70 mm (mean ± standard deviation: 45.8 ± 25.4). Main histology of gastric carcinoma involved poorly differentiated adenocarcinoma in five of
the six cases (Case 1, 2, 3, 4, and 6), while the remaining case involved papillary adenocarcinoma (Case 5). Although all cases more or less showed lymph-
vascular involvement, lymphatic involvement was prominent. Case 1 and 2 involved clinically proven and denied pulmonary hypertension, respectively.
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Page 3 of 9Figure 1 Macroscopic and histopathological findings of gastric carcinomas in case 1 and 2. Case 1 (A) The ulcerated tumor with relatively
demarcated and raised margins (Borrmann’s type 3 tumor) was located in the gastric body. (B and C) Poorly differentiated adenocarcinoma cells
diffusely proliferated (hematoxylin-eosin (HE) double stain, × 100, × 400, respectively). Case 2 (D) The ulcerated tumor with demarcated and
slightly raised margins (Borrmann’s type 2 tumor) was located in the gastric body. (E and F) Poorly differentiated adenocarcinoma cells were
arranged in small nests or trabecular pattern surrounded by fibrous stroma (HE double stain, × 100, × 400, respectively).
Figure 2 Scatter plots of pulmonary arterial diameter and stenosis rate in pulmonary arteries. There was a significant negative
association between pulmonary arterial diameter and stenosis rate in four of the six cases (Case 1, 2, 3, and 6). In contrast, there was no
significant association in the remaining two cases (Case 4 and 5).
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the life of patients with PTTM.
According to previous research [1,2], the incidence of
PTTM in autopsy cases with gastric carcinoma has been
reported ranging from 16.7% (6 PTTM cases among 36
gastric carcinoma patients) to 26.8% (11 PTTM cases
among 41 gastric carcinoma patients). Similarly, our study
revealed an incidence of 16.2% (6 PTTM cases among 37
gastric carcinoma patients), which is largely consistent
with these previous reports. In addition, the most common
histological type of gastric carcinoma in the present study
was poorly differentiated adenocarcinoma (five of the six
cases). This fact is also consistent with the previous studies
which reported that the most common tumor associated
with PTTM is poorly differentiated adenocarcinoma [1,2].
We now wish to discuss PTTM in more detail from
the viewpoint of our morphometric analysis of pulmon-
a r ya r t e r i e s .S i n c es o m ep a t i e n t sw i t hP T T Ms u f f e r e d
from pulmonary hypertension, we suggested that pul-
monary arterial remodeling induced by carcinoma cell
adhesion onto the endothelium affected the status of
pulmonary hypertension. Therefore, in the present
study, morphometric analysis was carried out on pul-
monary arteries. Results showed that the degree of lumi-
nal narrowing of the pulmonary arteries varied from
Figure 3 Histopathological findings of pulmonary tumor thrombotic microangiopathy in case 1. (A and B) Fibrocellular intimal
proliferation occludes the lumen of the pulmonary artery under 100 μm in diameter (Hematoxylin-eosin (HE) double stain and elastica van
Gieson (EVG) stain, × 400). (C and D) Fibrocellular intimal proliferation associated with carcinoma cells proliferation occludes the lumen of the
pulmonary artery over 300 μm in diameter (HE double stain and EVG stain, × 40).
Table 2 The relationship between optional stenosis rate
and each arterial group
Case Arterial group Stenosis rate (%)
Over 50% Over 40% Over 20% Over 10%
1 under 100-μm 76.5 76.5 76.5 76.5
100 to 300-μm 60.5 68.4 81.6 86.8
over 300-μm 10.7 35.7 64.3 82.1
2 under 100-μm 13.3 13.3 60.0 86.7
100 to 300-μm 0.0 21. 1 38.6 64.9
over 300-μm 0.0 0.0 3.4 6.9
3 under 100-μm 30.3 48.5 84.8 87.9
100 to 300-μm 38.0 52.0 84.0 88.0
over 300-μm 0.0 0.0 11.8 23.5
4 under 100-μm 43.8 50.0 62.5 62.5
100 to 300-μm 57.1 57.1 69.6 73.2
over 300-μm 25.0 35.7 46.4 50.0
5 under 100-μm 9.4 12.5 12.5 12.5
100 to 300-μm 19.0 22.4 31.0 34.5
over 300-μm 0.0 10.7 28.6 28.6
6 under 100-μm 0.0 12.5 50.0 59.4
100 to 300-μm 9.2 16.9 29.2 38.5
over 300-μm 0.0 0.0 11.1 22.2
Although all cases more or less showed an increase of the stenosis rate, the
degree of change in stenosis rate varied from case to case. In particular, case
1 showed widespread severe stenosis in the pulmonary artery.
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because pulmonary arterial pressure was evaluated only
in these two cases. Case 1 involved clinically proven pul-
monary hypertension and revealed widespread severe
stenosis in the pulmonary artery that showed a signifi-
cant negative association between arterial diameter and
luminal stenosis rate, as well as pulmonary arterial
hypertension as reported by Heath and Edwards [1]. In
contrast, case 2 involved clinically denied pulmonary
hypertension and showed a significant negative associa-
tion between arterial diameter and luminal stenosis rate.
However, its stenosis was milder and involved a smaller
artery in comparison to case 1. Accordingly, the occur-
rence of pulmonary hypertension may require a wide-
spread pulmonary lesion with severe luminal narrowing.
That is, pulmonary hypertension in a patient with PTTM
may occur in the case of which distribution of pulmonary
lesion is similar to that shown by a pulmonary
hypertension case. Then, we prefer to make a little discus-
sion on the histopathological difference between PTTM
and pulmonary arterial hypertension (PAH). The initial
event of PAH is understood as luminal stenosis due to a
symmetric intimal or medial thickening involving a term-
inal arteriole with a diameter less than 100 μm [8]. How-
ever, quite interestingly, our statistical analysis revealed no
significant difference for average stenosis rate between the
under 100-μm group and the 100 to 300-μm group in the
all PTTM cases of this study. These results suggest that
carcinoma cell adhesion onto the endothelium in PTTM
tends to start from larger arteries rather than a terminal
pulmonary arteriole.
Incidentally, VEGF and/or TF expression by carci-
noma cells has been confirmed in many cases of PTTM
[2-7]. VEGF has been known as an endothelial cell-
specific angiogenetic mitogen and is upregulated by TF
[2]. Furthermore, Takahashi et al. reported a case of
Figure 4 Histopathological findings of pulmonary tumor thrombotic microangiopathy in case 2. (A and B) Fibrocellular intimal
proliferation occludes the lumen of the pulmonary artery under 100 μm in diameter (Hematoxylin-eosin (HE) double stain and elastica van
Gieson (EVG) stain, × 400). (C and D) Neither prominent fibrocellular intimal proliferation nor carcinoma cells were present in the pulmonary
artery over 300 μm in diameter (HE double stain and EVG stain, × 40).
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OPN promotes thrombus formation, local activation of
coagulatory events, and pulmonary hypertension in the
pathogenesis of PTTM. Therefore, we also performed
immunohistochemical examinations of both gastric and
pulmonary tissue sections from each patient. In the pre-
sent study, 100% (6/6), 83.3% (5/6) and 50.0% (3/6) of
PTTM cases showed positive reactivity for TF, VEGF,
and OPN, respectively. It has been reported that 25.1%
(52/207) [10], 76.4% (113/148) [11], and 69.5% (205/
295) [12] of gastric carcinoma cases show positive reac-
tivity for TF, VEGF, and OPN, respectively. Accordingly,
our immunohistochemical examination indicated that
gastric carcinoma of PTTM shows a higher TF-positive
rate than typical gastric carcinoma. However, it still
remains obscuring whether gastric carcinoma inducing
PTTM shows a higher immunohistochemical positive
rate for VEGF or OPN because typical gastric carcinoma
also shows a high immunohistochemical positive rate for
these entities. Moreover, no significant difference was
found in characteristics of phenotypic expression of
VEGF or OPN for gastric adenocarcinoma cells between
those with and without PTTM, which represents an
unknown and important factor that may influence the
development of PTTM.
Figure 5 Average stenosis rate in each arterial group for six patients with pulmonary tumor thrombotic microangiopathy. No significant
differences were found for average stenosis rate between the under 100-μm group and the 100 to 300-μm group in all cases. On the other hand,
significant differences were found for average stenosis rate between the under 100-μm group or 100 to 300-μm group and the 300-μm group in
four of the six cases (Case 1, 2, 3, and 6). Statistical significance was tested using the one-way analysis of variance (ANOVA) and the Bonferroni post
hoc test. Values are expressed as mean ± standard deviation. Differences were considered significant at P < 0.05 (*: P < 0.05, ns: P > 0.05).
Table 3 The average stenosis rate in each arterial
group (%)
Case under 100 μm 100 to 300 μm over 300 μm
1 66.5 ± 36.3 48.8 ± 24.9 30.4 ± 21.8
2 25.5 ± 16.7 23.8 ± 23.1 2.5 ± 4.8
3 38.3 ± 19.6 39.7 ± 22.0 6.1 ± 9.7
4 31.7 ± 27.4 45.1 ± 31.8 28.7 ± 30.9
5 10.9 ± 25.6 17.9 ± 26.9 9.6 ± 15.5
6 19.4 ± 16.8 16.4 ± 21.0 6.5 ± 10.1
The pulmonary arteries were divided into three groups according to the
Heath-Edwards classification, such as artery under 100 μm, 100 to 300 μm, or
over 300 μm in diameter (designated the ‘under 100-μm’ group, the ‘100 to
300-μm’ group, and the ‘over 300-μm’ group, respectively). This table
surmised the average stenosis rate in each arterial group. Values are
expressed as mean ± standard deviation.
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In the present study, we examined six cases of PTTM,
histopathologically, and revealed that the degree of
luminal narrowing of the pulmonary arteries varied
from case to case. Our results suggested that pulmon-
ary hypertension in PTTM occurs in selected cases
which have a widespread pulmonary lesion with
severe luminal narrowing in the smaller arteries.
Furthermore, the immunohistochemical examination
indicated that gastric carcinoma inducing PTTM
shows a higher TF-positive rate than typical gastric
carcinoma. However, it still remains obscuring.
Further investigations should be required to know
whether gastric carcinoma inducing PTTM shows a
higher VEGF or OPN-positive rate as determined by
immunohistochemistry.
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